vs
Side-by-side financial comparison of GERON CORP (GERN) and GLADSTONE COMMERCIAL CORP (GOOD). Click either name above to swap in a different company.
GERON CORP is the larger business by last-quarter revenue ($47.2M vs $41.9M, roughly 1.1× GLADSTONE COMMERCIAL CORP). GLADSTONE COMMERCIAL CORP runs the higher net margin — 16.6% vs -39.0%, a 55.7% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs -3.6%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 6.3%).
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.
Gladstone Commercial Corp is a publicly traded US real estate investment trust focused on acquiring, owning, and operating diversified industrial and commercial properties. It offers long-term net lease agreements to tenants across manufacturing, logistics, healthcare and professional services sectors, mainly serving small to mid-sized business clients.
GERN vs GOOD — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $47.2M | $41.9M |
| Net Profit | $-18.4M | $7.0M |
| Gross Margin | — | — |
| Operating Margin | -29.4% | 160.2% |
| Net Margin | -39.0% | 16.6% |
| Revenue YoY | 67.1% | -3.6% |
| Net Profit YoY | 30.3% | 29.5% |
| EPS (diluted) | $-0.03 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $41.9M | ||
| Q4 25 | — | $43.5M | ||
| Q3 25 | $47.2M | $40.8M | ||
| Q2 25 | $49.0M | $39.5M | ||
| Q1 25 | $39.6M | $37.5M | ||
| Q4 24 | — | $37.4M | ||
| Q3 24 | $28.3M | $39.2M | ||
| Q2 24 | $882.0K | $37.1M |
| Q1 26 | — | $7.0M | ||
| Q4 25 | — | $5.4M | ||
| Q3 25 | $-18.4M | $4.1M | ||
| Q2 25 | $-16.4M | $4.6M | ||
| Q1 25 | $-19.8M | $5.1M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-26.4M | $11.7M | ||
| Q2 24 | $-67.4M | $1.6M |
| Q1 26 | — | 160.2% | ||
| Q4 25 | — | — | ||
| Q3 25 | -29.4% | — | ||
| Q2 25 | -25.4% | — | ||
| Q1 25 | -42.2% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -99.8% | — | ||
| Q2 24 | -7860.9% | — |
| Q1 26 | — | 16.6% | ||
| Q4 25 | — | 12.4% | ||
| Q3 25 | -39.0% | 10.1% | ||
| Q2 25 | -33.4% | 11.7% | ||
| Q1 25 | -50.1% | 13.7% | ||
| Q4 24 | — | 19.2% | ||
| Q3 24 | -93.5% | 29.8% | ||
| Q2 24 | -7639.8% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.05 | ||
| Q3 25 | $-0.03 | $0.02 | ||
| Q2 25 | $-0.02 | $0.03 | ||
| Q1 25 | $-0.03 | $0.04 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-0.04 | $0.20 | ||
| Q2 24 | $-0.10 | $-0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $248.7M | — |
| Total Assets | $567.4M | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $10.8M | ||
| Q3 25 | $78.1M | $18.4M | ||
| Q2 25 | $77.7M | $11.7M | ||
| Q1 25 | $83.7M | $10.4M | ||
| Q4 24 | — | $11.0M | ||
| Q3 24 | $60.3M | $10.5M | ||
| Q2 24 | $116.9M | $10.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $843.5M | ||
| Q3 25 | — | $843.3M | ||
| Q2 25 | — | $794.4M | ||
| Q1 25 | — | $740.7M | ||
| Q4 24 | — | $693.4M | ||
| Q3 24 | — | $692.6M | ||
| Q2 24 | — | $722.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $171.8M | ||
| Q3 25 | $248.7M | $184.8M | ||
| Q2 25 | $259.5M | $177.2M | ||
| Q1 25 | $268.2M | $183.2M | ||
| Q4 24 | — | $171.2M | ||
| Q3 24 | $292.3M | $168.9M | ||
| Q2 24 | $306.7M | $145.7M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | — | $1.2B | ||
| Q3 25 | $567.4M | $1.3B | ||
| Q2 25 | $555.2M | $1.2B | ||
| Q1 25 | $562.5M | $1.2B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | $444.9M | $1.1B | ||
| Q2 24 | $449.4M | $1.1B |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.91× | ||
| Q3 25 | — | 4.56× | ||
| Q2 25 | — | 4.48× | ||
| Q1 25 | — | 4.04× | ||
| Q4 24 | — | 4.05× | ||
| Q3 24 | — | 4.10× | ||
| Q2 24 | — | 4.96× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-13.6M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $88.2M | ||
| Q3 25 | $-13.6M | $18.9M | ||
| Q2 25 | $-27.4M | $35.8M | ||
| Q1 25 | $-48.0M | $17.7M | ||
| Q4 24 | — | $57.0M | ||
| Q3 24 | $-58.9M | $5.5M | ||
| Q2 24 | $-53.5M | $13.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-53.7M | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -6086.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 23.4% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | 16.38× | ||
| Q3 25 | — | 4.57× | ||
| Q2 25 | — | 7.74× | ||
| Q1 25 | — | 3.44× | ||
| Q4 24 | — | 7.93× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 8.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
